Literature DB >> 16085558

Disseminated intravascular coagulation complicating acute lymphoblastic leukemia: a study of childhood and adult cases.

Takakazu Higuchi1, Daisuke Toyama, Yasuzou Hirota, Keiichi Isoyama, Hiraku Mori, Haruo Niikura, Kouichiro Yamada, Mitsuhiro Omine.   

Abstract

A high incidence of disseminated intravascular coagulation (DIC) in adult patients with acute lymphoblastic leukemia (ALL) is reported. However, studies comprising both childhood and adult patients are sparse and the clinical relevance of DIC in ALL patients has been a conflicting issue. Coagulation profiles at presentation and within seven days after starting remission-induction therapy of 44 childhood and 51 adult ALL patients were studied. At presentation, two childhood (5%) and 11 adult (22%) patients had DIC (p<0.05). After starting therapy, four of 27 childhood (15%) and 14 of 33 adult (42%) patients screened for coagulopathy developed DIC (p<0.05). Overall, six of the 44 children (14%) and 25 of the 51 adults (49%) were complicated with DIC (p<0.001). In the adult cases, DIC was more frequently complicated with FAB subtype L2 than L1 (p<0.05). All hemorrhages seen in the childhood cases were minor hemorrhages. In the adult patients, two patients with DIC had WHO grade 3 hemorrhage and the other hemorrhagic complications were minor hemorrhages. While milder induction therapies starting with corticosteroid given for childhood cases should be taken into consideration when comparing the incidences of DIC after therapy, the findings indicated that childhood and adult ALL may differ in the procoagulant characteristics. Morphological distinction between L1 and L2 appears to have relevance in the procoagulant activity in adult ALL. DIC complicating ALL is generally mild, however, sometimes causes severe hemorrhages in adults.

Entities:  

Mesh:

Year:  2005        PMID: 16085558     DOI: 10.1080/10428190500102662

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  8 in total

1.  Management of hemostatic complications in acute leukemia: Guidance from the SSC of the ISTH.

Authors:  Tzu-Fei Wang; Robert S Makar; Darko Antic; Jerrold H Levy; James D Douketis; Jean M Connors; Marc Carrier; Jeffrey I Zwicker
Journal:  J Thromb Haemost       Date:  2020-12       Impact factor: 5.824

Review 2.  Treatment for disseminated intravascular coagulation in patients with acute and chronic leukemia.

Authors:  Arturo J Martí-Carvajal; Vidhu Anand; Ivan Solà
Journal:  Cochrane Database Syst Rev       Date:  2015-06-24

3.  Prevalence and clinical characteristics of acute myeloid leukemia associated with disseminated intravascular coagulation.

Authors:  Hideki Uchiumi; Takafumi Matsushima; Arito Yamane; Noriko Doki; Hiroyuki Irisawa; Takayuki Saitoh; Tohru Sakura; Takahiro Jimbo; Hiroshi Handa; Norifumi Tsukamoto; Masamitsu Karasawa; Shuichi Miyawaki; Hirokazu Murakami; Yoshihisa Nojima
Journal:  Int J Hematol       Date:  2007-08       Impact factor: 2.490

4.  Acute lymphoblastic leukemia presenting with gross hematuria.

Authors:  Naifain Al Kalbani; Sheila Weitzman; Mohamed Abdelhaleem; Manuel Carcao; Oussama Abla
Journal:  Paediatr Child Health       Date:  2007-09       Impact factor: 2.253

5.  Prediction of life-threatening and disabling bleeding in patients with AML receiving intensive induction chemotherapy.

Authors:  Jurjen Versluis; Manu Pandey; Yael Flamand; J Erika Haydu; Roger Belizaire; Mark Faber; Rahul S Vedula; Anne Charles; Kevin M Copson; Shai Shimony; Alon Rozental; Pavan K Bendapudi; Ofir Wolach; Elizabeth A Griffiths; James E Thompson; Richard M Stone; Daniel J DeAngelo; Donna Neuberg; Marlise R Luskin; Eunice S Wang; R Coleman Lindsley
Journal:  Blood Adv       Date:  2022-05-10

6.  SIL-TAL1 rearrangement is related with poor outcome: a study from a Chinese institution.

Authors:  Di Wang; Guangrong Zhu; Na Wang; Xiaoxi Zhou; Yunfan Yang; Shiqiu Zhou; Jie Xiong; Jing He; Lijun Jiang; Chunrui Li; Danmei Xu; Liang Huang; Jianfeng Zhou
Journal:  PLoS One       Date:  2013-09-09       Impact factor: 3.240

7.  Use of a stop-flow programmable shunt valve to maximize CNS chemotherapy delivery in a pediatric patient with acute lymphoblastic leukemia.

Authors:  Sheri K Palejwala; David A Stidd; Jesse M Skoch; Puja Gupta; G Michael Lemole; Martin E Weinand
Journal:  Surg Neurol Int       Date:  2014-08-21

8.  Clinical Features of Disseminated Intravascular Coagulation According to the French-American-British Classification in Patients With Acute Leukemia and Thrombomodulin Alfa Treatment-A Cohort Study Using a Postmarketing Surveillance Database.

Authors:  Seki Yoshinobu; Goichi Honda; Noriaki Kawano; Toshimasa Uchiyama; Kazuo Kawasugi; Seiji Madoiwa; Naoki Takezako; Ikezoe Takayuki; Hideo Wada
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.